Publisher
Springer Berlin Heidelberg
Reference7 articles.
1. Al Rihani, S. B., Deodhar, M., Darakjian, L. I., Dow, P., Smith, M. K., Bikmetov, R., et al. (2021). Quantifying anticholinergic burden and sedative load in older adults with polypharmacy: A systematic review of risk scales and models. Drugs & Aging, 38(11), 977–994. https://doi.org/10.1007/s40266-021-00895-x
2. Glass, J. R., Sproule, B. A., Herrmann, N., & Busto, U. E. (2008). Effects of 2-week treatment with temazepam and diphenhydramine in elderly insomniacs: A randomized, placebo-controlled trial. Journal of Clinical Psychopharmacology, 28(2), 182–188. https://doi.org/10.1097/JCP.0b013e31816a9e4f
3. Gray, S. L., Anderson, M. L., Dublin, S., Hanlon, J. T., Hubbard, R., Walker, R., et al. (2015). Cumulative use of strong anticholinergics and incident dementia: A prospective cohort study. JAMA Internal Medicine, 175(3), 401–407. https://doi.org/10.1001/jamainternmed.2014.7663
4. Katayose, Y., Aritake, S., Kitamura, S., Enomoto, M., Hida, A., Takahashi, K., & Mishima, K. (2012). Carryover effect on next-day sleepiness and psychomotor performance of nighttime administered antihistaminic drugs: A randomized controlled trial. Human Psychopharmacology, 27(4), 428–436. https://doi.org/10.1002/hup.2244
5. Meolie, A. L., Rosen, C., Kristo, D., Kohrman, M., Gooneratne, N., Aguillard, R. N., et al. (2005). Oral nonprescription treatment for insomnia: An evaluation of products with limited evidence. Journal of Clinical Sleep Medicine: JCSM: Official Publication of the American Academy of Sleep Medicine, 1(2), 173–187. Review.